NeoGenomics Q1 Revenues Jump on Genetic Test Volume Growth | GenomeWeb

This article has been updated with comments from a conference call following the release of the firm's financial results.

NEW YORK (GenomeWeb) – NeoGenomics reported today a 159 percent increase in its first quarter revenues driven by increases in both base and clinical genetic test volume growth. 

For the three-month period ended March 31, the company posted revenues of $59.7 million compared with $23 million a year earlier, topping Wall Street's consensus estimate of $57 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

Sponsored by

This webinar will discuss a partnership model for noninvasive prenatal testing that enabled LifeLabs Genetics, a genetic testing lab based in Toronto, Ontario, to implement NIPT in house.